Recombinant human interferon gamma therapy for osteopetrosis
- 31 July 1992
- journal article
- research article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 121 (1), 119-124
- https://doi.org/10.1016/s0022-3476(05)82557-0
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo.JCI Insight, 1990
- Partial Correction of the Phagocyte Defect in Patients with X-Linked Chronic Granulomatous Disease by Subcutaneous Interferon GammaNew England Journal of Medicine, 1988
- Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gammaJournal of Bone and Mineral Research, 1986
- Phase I study of multiple dose intramuscularly administered recombinant gamma interferon.Journal of Clinical Oncology, 1986
- Congenital Osteopetrotic Mutations as Probes of the Origin, Structure, and Function of OsteoclastsClinical Orthopaedics and Related Research, 1984
- Treatment of Congenital Osteopetrosis with High-Dose CalcitriolNew England Journal of Medicine, 1984
- Successful Bone-Marrow Transplantation for Infantile Malignant OsteopetrosisNew England Journal of Medicine, 1980
- Quantitative Nitroblue Tetrazolium Test in Chronic Granulomatous DiseaseNew England Journal of Medicine, 1968